Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 10:23 PM
Ignite Modification Date:
2025-12-24 @ 10:23 PM
NCT ID:
NCT02675335
Eligibility Criteria:
Inclusion Criteria:
* type 2 diabetes mellitus
* at least 1 diabetic foot ulcer with a size between 1 and 20 sqcm
* stable size of the foot ulcer for at least 2 weeks
* HbA1c \<= 8% under Treatment with Insulin, metformin, sulfonylureas, SGLT2 Inhibitors, glinides or glitazones
Exclusion Criteria:
* local purulent signs of Inflammation at ulcer site
* planned interventional or surgical therapy of a macro vessel disease of the lower limb
* glomerular filtration rate \<30ml/min
* liver cirrhosis CHILD B or C
* pregnancy, lactation
* allergy against Sitagliptin
* ongoing treatment with dipeptidyl peptidase 4 (DPP4) Inhibitors
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
100 Years
Study:
NCT02675335
Study Brief:
Protocol Section:
NCT02675335